Abstract
The increasing interest in molecular diagnostics is a result of tremendously improved knowledge on fungal infections in the past 20 years and the rapid development of new methods, in particular polymerase chain reaction. High expectations have been placed on molecular diagnostics, and the number of laboratories now using the relevant technology is rapidly increasing—resulting in an obvious need for standardization and definition of laboratory organization. In the past 10 years, multiple new molecular tools were marketed for the detection of DNA, antibodies, cell wall components, or other antigens. In contrast to classical culture methods, molecular methods do not detect a viable organisms, but only molecules which indicate its presence; this can be nucleic acids, cell components (antigens), or antibodies (Fig. 1). In this chapter, an overview is provided on commercially available detection tools, their strength and how to use them. A main focus is laid on providing tips and tricks that make daily life easier. We try to focus and mention methodical details which are not highlighted in the manufacturer’s instructions of these test kits, but are based on our personal experience in the laboratory. Important to keep in mind is that molecular tools cannot replace culture, microscopy, or a critical view on patients’ clinical history, signs, and symptoms, but provide a valuable add on tool. Diagnosis should not be based solely on a molecular test, but molecular tools might deliver an important piece of information that helps matching the diagnostic puzzle to a diagnosis, in particular as few tests are in vitro diagnostic tests (IVD) or only part of the whole test carries the IVD certificate (e.g., DNA extraction is often not included). Please be aware that the authors do not claim to provide a complete overview on all commercially available diagnostic assays being currently marketed for fungal detection, as those are subject to constant change. A main focus is put on commonly used panfungal assays and pathogen-specific assays, including Aspergillus-specific, Candida-specific, Cryptococcus specific, Histoplasma-specific, and Pneumocystis-specific assays. Assays are categorized according to their underlying principle in either antigen-detecting or antibody-detecting or DNA-detecting (Fig. 1). Other non-DNA-detecting nucleic acid methods such as FISH and PNA FISH are not summarized in this chapter and an overview on test performance, common false positives, and the clinical evaluation of commercial tests in studies is provided already in a previous book series by Javier Yugueros Marcos and David H. Pincus (Marcos and Pincus, Methods Mol Biol 968:25–54, 2013).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Harrison E, Stalhberger T, Whelan R et al (2010) Aspergillus DNA contamination in blood collection tubes. Diagn Microbiol Infect Dis 67:392–394
Alanio AB, S. (2014) Diagnosis of Pneumocystis jirovecii pneumonia: role of β-D-glucan detection and PCR. Curr Fungal Infect Rep 8:322–330
Neumaier M, Braun A, Wagener C (1998) Fundamentals of quality assessment of molecular amplification methods in clinical diagnostics. International Federation of Clinical Chemistry Scientific Division Committee on Molecular Biology Techniques. Clin Chem 44:12–26
LIFE, Cheshire, UK. http://www.life-worldwide.org/. Accessed 7 Oct 2015
Anonymous (2013) UK Standards for Microbiological Investigations: Good Laboratory Practice when Performing Molecular Amplification Assays. In: Standard Unit MS, Public Health England (ed) Public Health England (PHE) National Health Services (NHS), London, pp 1–15
Baxter CG, Denning DW, Jones AM et al (2013) Performance of two Aspergillus IgG EIA assays compared with the precipitin test in chronic and allergic aspergillosis. Clin Microbiol Infect 19:e197–e204
Beutler E, Gelbart T, Kuhl W (1990) Interference of heparin with the polymerase chain reaction. Biotechniques 9:166
Chen SC, Kontoyiannis DP (2010) New molecular and surrogate biomarker-based tests in the diagnosis of bacterial and fungal infection in febrile neutropenic patients. Curr Opin Infect Dis 23:567–577
Chong L (2001) Molecular cloning—a laboratory manual, 3rd edition. Science 292:446
Chumpitazi BF, Lebeau B, Faure-Cognet O et al (2014) Characteristic and clinical relevance of Candida mannan test in the diagnosis of probable invasive candidiasis. Med Mycol 52:462–471
Cimino GD, Metchette KC, Tessman JW et al (1991) Post-PCR sterilization: a method to control carryover contamination for the polymerase chain reaction. Nucleic Acids Res 19:99–107
Fairfax MR, Metcalf MA, Cone RW (1991) Slow inactivation of dry PCR templates by UV light. PCR Methods Appl 1:142–143
Hauser PM, Bille J, Lass-Flörl C et al (2011) Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real-time PCR assay. J Clin Microbiol 49:1872–1878
Irinyi L, Lackner M, De Hoog GS, Meyer W (2015) DNA barcoding of fungi causing infections in humans and animals. Fungal Biol. In press. Doi: 10.1016/j.funbio.2015.04.007
Marcos JY, Pincus DH (2013) Fungal diagnostics: review of commercially available methods. Methods Mol Biol 968:25–54
Montesinos I, Brancart F, Schepers K et al (2015) Comparison of 2 real-time PCR assays for diagnosis of Pneumocystis jirovecii pneumonia in human immunodeficiency virus (HIV) and non-HIV immunocompromised patients. Diagn Microbiol Infect Dis 82:143–147
Gillespie DH, Cuddy KK, Kolbe T et al (1994) Dissolve and capture: a strategy for analysing mRNA in blood. Nature 367:390–391
Morris A, Lundgren JD, Masur H et al (2004) Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis 10:1713–1720
Thornton CR (2010) Detection of invasive aspergillosis. Adv Appl Microbiol 70:187–216
Verdaguer V, Walsh TJ, Hope W et al (2007) Galactomannan antigen detection in the diagnosis of invasive aspergillosis. Expert Rev Mol Diagn 7:21–32
Williams DA, Kiiza T, Kwizera R et al (2015) Evaluation of fingerstick cryptococcal antigen lateral flow assay in HIV-infected persons: a diagnostic accuracy study. Clin Infect Dis. In press. doi: 10.1093/cid/civ263
Acknowledgement
We are thankful to the tips and tricks and remarks provided by staff of molecular routine laboratory Alexander Engl, Michaela Mayer, Raphaela Löffler, and Wolfgang Mutschlechner.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this protocol
Cite this protocol
Lackner, M., Lass-Flörl, C. (2017). Commercial Molecular Tests for Fungal Diagnosis from a Practical Point of View. In: Lion, T. (eds) Human Fungal Pathogen Identification. Methods in Molecular Biology, vol 1508. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6515-1_4
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6515-1_4
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6513-7
Online ISBN: 978-1-4939-6515-1
eBook Packages: Springer Protocols